Detecting adverse drug events
Processing safety reports
Indeed, the use of AI and ML technology in Pharmaceuticals and Life sciences has come a long way. Be it in regulatory affairs, medico-regulatory writing, or pharmacovigilance- the pharmaceutical sector is experiencing exponential technological growth to enhance operations and processes. Particularly in pharmacovigilance and drug safety, exploiting advanced technology is resulting in better & more accurate real-world data that provides a better understanding of a drug’s safety profile, to ensure patient safety and minimize risk of ADEs.
 Alvaro N, Conway M, Doan S, Lofi C, Overington J, Collier N. Crowdsourcing Twitter annotations to identify first-hand experiences of prescription drug use. Journal of biomedical informatics. 2015 Dec 1;58:280-7.
 Basile AO, Yahi A, Tatonetti NP. Artificial intelligence for drug toxicity and safety. Trends in pharmacological sciences. 2019 Sep 1;40(9):624-35.
 Ménard T, Barmaz Y, Koneswarakantha B, Bowling R, Popko L. Enabling data-driven clinical quality assurance: predicting adverse event reporting in clinical trials using machine learning. Drug safety. 2019 Sep;42(9):1045-53.
 Evans HP, Anastasiou A, Edwards A, Hibbert P, Makeham M, Luz S, Sheikh A, Donaldson L, Carson-Stevens A. Automated classification of primary care patient safety incident report content and severity using supervised machine learning (ML) approaches. Health informatics journal. 2020 Dec;26(4):3123-39.
 Marella WM, Sparnon E, Finley E. Screening electronic health record–related patient safety reports using machine learning. Journal of Patient Safety. 2017 Mar 1;13(1):31-6.
 Bouzillé G, Morival C, Westerlynck R, Lemordant P, Chazard E, Lecorre P, Busnel Y, Cuggia M. An Automated Detection System of Drug-Drug Interactions from Electronic Patient Records Using Big Data Analytics. InMedInfo 2019 Aug 21 (pp. 45-49).